AIによる処方適正化支援

家

AIプロンプト一覧

医療健康

処方審査アシスタント

${:__('collect %s',処方審査アシスタント)}$

医療健康

患者の病歴と投薬記録に基づき、潜在的な薬物相互作用や禁忌を自動で特定し、標準化された審査レポートを生成します。

プロンプト内容

コピー

Act as a clinical pharmacy assistant. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, for prescription compliance. Focus on analyzing drug-drug interactions, dosage appropriateness, contraindications, and suitability for specific physiological states (e.g., renal impairment or pregnancy). Identify all potential risks and provide specific adjustment suggestions or warnings based on the latest clinical guidelines. Finally, output a structured, professional audit report to ensure medication safety.

コピー

臨床薬剤師のアシスタントとして、提供された患者の電子健康記録（病歴、アレルギー、現在の服薬リスト、検査結果を含む）に基づき、処方箋の適正性を審査してください。薬物間の相互作用、投与量の適切さ、禁忌、および特定の生理状態（腎機能不全や妊娠など）への適合性に重点を置いて分析してください。すべての潜在的なリスクを特定し、最新の臨床ガイドラインに基づいて具体的な調整提案や警告を提供してください。最後に、安全性を確保するための構造化された専門的な審査レポートを出力してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription data. First, extract the patient's age, gender, weight, liver and kidney function indicators, and current medication list. Second, based on the latest clinical guidelines, analyze the interaction risks between newly prescribed drugs and existing medications, focusing on contraindications, dosage limits, and administration route appropriateness. Finally, if any potential risks are identified, clearly specify the conflict points and provide evidence-based alternative solutions or adjustment recommendations to ensure the output is clear, professional, and directly supports clinical decision-making.

処方審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.